Virtuoso Surgical (2024)

About this raise

Virtuoso Surgical is raising funds through Reg A+ crowdfunding with Deer Isle Capital as the Broker-Dealer. It is a MedTech company that creates robotic tools to aid surgeons. The company attempts to better patient outcomes by offering technology to make surgeries minimally invasive with its dexterous, accurate, and cost-effective robotic tools. Virtuoso Surgical has licensed its rights to patents to John Hopkins University and Vanderbilt University. Richard Hendrick and Robert Webster founded Virtuoso Surgical in April 2016. The current crowdfunding campaign has a maximum target of $20 million. The campaign proceeds will be used for continued product development, working capital, sales and marketing, and research and development.

Investment Overview

Committed [Withdrawn]: $2,000,000

Deal Terms
Company & Team

Logos provided by Clearbit

Platform: C2M Securities
Start Date: 09/06/2022
Close Date: 02/20/2024

Min. Goal
$1,020

Max Goal
$20,000,000

Min. Investment

$1,020

Security Type

Equity - Common

Company Stage

Growth Stage

SEC Filing Type

RegA+

Price Per Share

$60.00

Pre-Money Valuation

$29,149,210

Company

Year Founded: 2016
Industry: Healthcare & Pharmaceuticals
Tech Sector: Medtech
Distribution Model: B2B
Margin: Medium
Capital Intensity: High
Location: NASHVILLE, Tennessee
Business Type: Growth
Company Website: Visit Website

Team

Employees: 7
Prior Founder Exits?: No

Founder Name: Robert Webster
Title: President and Chief Technology Officer

Founder Name: Richard Hendrick
Title: Chief Operating Officer

Founder Name: Duke Herrell
Title: Chief Medical Officer

Funding data not publicly available

Financials

Revenue: $0
Monthly Burn: $184,352
Runway: 7.1 months

View Detailed Financials

Balance Sheet

Cash and Cash Equivalents	$1,312,227
Investment Securities	$401,058
Property, Plant and Equipment (PP&E)	$1,714,384
Total Assets	$3,490,535

Accounts Payable & Accrued Liabilities	$349,753
Long Term Debt	$0
Total Liabilities	$349,753
Total Stockholders' Equity	$3,140,782
Total Liabilities and Equity	$3,490,535

Statement of Comprehensive Income Information

Costs & Expenses Applicable to Rev	$2,917,804
Depreciation and Amortization	$64,797
Net Income	$-2,212,226

Earnings Per Share - Basic	$-2.04
Earnings Per Share - Diluted	$-2.04

Auditor: Blankenship CPA Group, PLLC

Create a free account today to gain access to Kingscrowd analytics and financials.

Pay Monthly

Annually (2 months free)

: $12.50 /month
billed annually; Free portfolio tracking, data-driven ratings, AI analysis and reports; Plan Includes:; Everything in Free, plus; Company specific Kingscrowd ratings and analyst reports; Deal explorer and side-by-side comparison; Startup exit and failure tracking; Startup market filters and historical industry data; Advanced company search ( with ratings); Get Edge Annual Get Edge Monthly

Already a member? Log in here.

Ratings

Total Prior Capital Raised: $9,000,000
Grants: $300,000
VC Backed?: No

Offering Name	Close Date	Platform	Valuation	Total Raised	Security Type	Status	Reg Type
Virtuoso Surgical	02/20/2024	C2M Securities	$29,149,210	$2,000,000	Equity - Common	Withdrawn	RegA+
Virtuoso Surgical, Inc.	05/31/2022	C2M Securities	$6,927,500	-	Equity - Preferred	Funded	RegA+

Create a free account today to gain access to Kingscrowd analytics.

Revenue
Valuation
Price per Share
Employees

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Valuation History

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Employee History

Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.

Withdrawn

Common Stock, $29.1M • Withdrawn

9 Following

Add to Portfolio

0 Invested

Deal Considerations

Key Challenges
- No key challenges found
1
Other Risks
- Try Edge free for 7 days

Virtuoso Surgical (2024)

Virtuoso Surgical (2024)

About this raise